| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Gilbert F Amelio is Director at GALT. Gilbert F Amelio's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $203K at current prices.
The GALT filings lean toward selling, a net 120,100 shares.
Gilbert F Amelio has 15 Form 4 filings on record from March 2015 to January 2026, all as Director at Galectin Therapeutics (GALT), 2015–2026.
The 25 reported transactions were 10 option or other derivative awards, 5 open-market sales, 3 stock awards and 3 dispositions back to the company, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $379K.
The largest open-market sale was 30,000 shares of GALT at an average $5.00 on January 31, 2019, about $150K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 11, 2021 | GALT Galectin Therapeutics Inc | Director | Sell | 60,000 | $2.17 | $130,200.00 | -49.7% | |
| Sep 5, 2019 | GALT Galectin Therapeutics Inc | Director | Sell | 30,000 | $3.30 | $99,000.00 | -19.4% | |
| Jan 31, 2019 | GALT Galectin Therapeutics Inc | Director | Sell | 30,000 | $5.00 | $150,000.00 | -16.3% | |
| Nov 30, 2015 | GALT Galectin Therapeutics Inc | Director | Sell | 100 | $2.10 | $210.00 | - |